These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 8359227)
1. The close relationship between DNA replication and the selection of differentiation lineages of human erythroleukemia cell lines K562, HEL, and TF1 into either erythroid or megakaryocytic lineages. Murate T; Saga S; Hotta T; Asano H; Ito T; Kato K; Tsushita K; Kinoshita T; Ichikawa A; Yoshida S Exp Cell Res; 1993 Sep; 208(1):35-43. PubMed ID: 8359227 [TBL] [Abstract][Full Text] [Related]
2. Aphidicolin, an inhibitor of DNA replication, blocks the TPA-induced differentiation of a human megakaryoblastic cell line, MEG-O1. Murate T; Hotta T; Tsushita K; Suzuki M; Yoshida T; Saga S; Saito H; Yoshida S Blood; 1991 Dec; 78(12):3168-77. PubMed ID: 1742484 [TBL] [Abstract][Full Text] [Related]
3. A functional role of mitogen-activated protein kinases, erk1 and erk2, in the differentiation of a human leukemia cell line, UT-7/GM: a possible key factor for cell fate determination toward erythroid and megakaryocytic lineages. Uchida M; Kirito K; Shimizu R; Miura Y; Ozawa K; Komatsu N Int J Hematol; 2001 Jan; 73(1):78-83. PubMed ID: 11372759 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of protein kinase C suppresses megakaryocytic differentiation and stimulates erythroid differentiation in HEL cells. Hong Y; Martin JF; Vainchenker W; Erusalimsky JD Blood; 1996 Jan; 87(1):123-31. PubMed ID: 8547633 [TBL] [Abstract][Full Text] [Related]
5. Expression of megakaryocytic and erythroid properties in human leukemic cells. Tani T; Ylänne J; Virtanen I Exp Hematol; 1996 Feb; 24(2):158-68. PubMed ID: 8641337 [TBL] [Abstract][Full Text] [Related]
6. Erythroid potentiating activity of tissue inhibitor of metalloproteinases on the differentiation of erythropoietin-responsive mouse erythroleukemia cell line, ELM-I-1-3, is closely related to its cell growth potentiating activity. Murate T; Yamashita K; Ohashi H; Kagami Y; Tsushita K; Kinoshita T; Hotta T; Saito H; Yoshida S; Mori KJ Exp Hematol; 1993 Jan; 21(1):169-76. PubMed ID: 8417953 [TBL] [Abstract][Full Text] [Related]
7. Induced myeloid differentiation of K562 cells with downregulation of erythroid and megakaryocytic transcription factors: a novel experimental model for hemopoietic lineage restriction. Green AR; Rockman S; DeLuca E; Begley CG Exp Hematol; 1993 Apr; 21(4):525-31. PubMed ID: 8462662 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of GATA-2 inhibits erythroid and promotes megakaryocyte differentiation. Ikonomi P; Rivera CE; Riordan M; Washington G; Schechter AN; Noguchi CT Exp Hematol; 2000 Dec; 28(12):1423-31. PubMed ID: 11146164 [TBL] [Abstract][Full Text] [Related]
9. The alpha1-adrenergic receptor antagonists, benoxathian and prazosin, induce apoptosis and a switch towards megakaryocytic differentiation in human erythroleukemia cells. Fuchs R; Stelzer I; Haas HS; Leitinger G; Schauenstein K; Sadjak A Ann Hematol; 2009 Oct; 88(10):989-97. PubMed ID: 19241077 [TBL] [Abstract][Full Text] [Related]
10. Levels of Smad7 regulate Smad and mitogen activated kinases (MAPKs) signaling and controls erythroid and megakaryocytic differentiation of erythroleukemia cells. Akel S; Bertolette D; Petrow-Sadowski C; Ruscetti FW Platelets; 2007 Dec; 18(8):566-78. PubMed ID: 18041647 [TBL] [Abstract][Full Text] [Related]
11. α1-Adrenergic drugs modulate differentiation and cell death of human erythroleukemia cells through non adrenergic mechanism. Fuchs R; Schraml E; Leitinger G; Stelzer I; Allard N; Haas HS; Schauenstein K; Sadjak A Exp Cell Res; 2011 Oct; 317(16):2239-51. PubMed ID: 21781962 [TBL] [Abstract][Full Text] [Related]
12. Differential expression of ras protooncogenes during in vitro differentiation of human erythroleukemia cells. Delgado MD; Quincoces AF; Gómez-Casares MT; Martínez CA; Cuadrado MA; Richard C; León J Cancer Res; 1992 Nov; 52(21):5979-84. PubMed ID: 1394224 [TBL] [Abstract][Full Text] [Related]
13. Regulation of both erythroid and megakaryocytic differentiation of a human leukemia cell line, UT-7. Miura Y; Kirito K; Komatsu N Acta Haematol; 1998; 99(3):180-4. PubMed ID: 9587401 [TBL] [Abstract][Full Text] [Related]
14. Constitutive expression of a megakaryocytic functional property by murine erythroleukemia (Friend) cells: the incorporation of serotonin. Vannucchi AM; Grossi A; Paoletti F; Rafanelli D; Bacci P; Ferrini PR Exp Hematol; 1992 Dec; 20(11):1296-301. PubMed ID: 1493858 [TBL] [Abstract][Full Text] [Related]
15. CDDO-Im is a stimulator of megakaryocytic differentiation. Petronelli A; Pelosi E; Santoro S; Saulle E; Cerio AM; Mariani G; Labbaye C; Testa U Leuk Res; 2011 Apr; 35(4):534-44. PubMed ID: 21035854 [TBL] [Abstract][Full Text] [Related]
16. Terminal differentiation of human erythroleukemia cell line K562 induced by aphidicolin. Murate T; Kagami Y; Hotta T; Yoshida T; Saito H; Yoshida S Exp Cell Res; 1990 Nov; 191(1):45-50. PubMed ID: 2121512 [TBL] [Abstract][Full Text] [Related]
17. Effects of activin A/erythroid differentiation factor on erythroid and megakaryocytic differentiations of mouse erythroleukemia (Friend) cells: evidence for two distinct modes of cell response. Okafuji K; Kaku K; Seguchi M; Tanaka H; Azuno Y; Kaneko T Exp Hematol; 1995 Mar; 23(3):210-6. PubMed ID: 7875239 [TBL] [Abstract][Full Text] [Related]
18. Characterization of hematopoietic lineage-specific gene expression by ES cell in vitro differentiation induction system. Era T; Takagi T; Takahashi T; Bories JC; Nakano T Blood; 2000 Feb; 95(3):870-8. PubMed ID: 10648398 [TBL] [Abstract][Full Text] [Related]
19. Sustained c-kit expression in a human erythroleukemia cell line (HEL) after megakaryocytic differentiation induced by 12-O-tetradecanoylphorbol-13-acetate (TPA). Bakić M; Ozawa K; Uemura N; Nishikawa M; Tojo A; Takahashi K; Tani K; Zaike Y; Ikebuchi K; Asano S Leuk Res; 1993 Dec; 17(12):1079-82. PubMed ID: 7504152 [TBL] [Abstract][Full Text] [Related]
20. Megakaryocytic differentiation induced by constitutive activation of mitogen-activated protein kinase kinase. Whalen AM; Galasinski SC; Shapiro PS; Nahreini TS; Ahn NG Mol Cell Biol; 1997 Apr; 17(4):1947-58. PubMed ID: 9121442 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]